NLRP3 and inflammatory bowel disease: Experiments observed the effects of NLRP3 deletion or inhibition or blocking oligomerization on the development of intestinal inflammation and concluded that the overactivation of NLRP3 inflammasome and its major cytokines promotes the development of IBD (127–131).